目的通过建立一种体外稳定培养单个造血干细胞(hematopoietic stem cell,HSC)的实验方法,在未来筛选可以促进HSC体外扩增的化合物。方法通过配制HSCs体外培养液并结合流式分选技术,我们建立了一种在体外不需要基质细胞支持的,稳定的,高通量培养单个HSC形成一个血细胞集落的实验方法。结果只需培养10~14 d即可观察到化合物对HSC的作用,并结合流式细胞分析技术替代人工计数血细胞分化情况,进一步节省人力,具有客观、重复性强的特点,满足了高通量筛选药物的要求,为后续的研究和化合物筛选工作打下基础。为了验证此方法的可靠性,使用BIO(一种通过抑制糖原合成酶激酶-3,进而可以促进HSC自我更新的化合物)时,实验结果与文献报道的研究结果一致。结论该实验方法在有关造血干细胞体外扩增的药物筛选方面具有很好的应用价值。
Aim To establish a method to stably culture a single HSC in vitro, to screen the compounds which can promote the self-renew of hematopoietic stem cells (HSCs). Methods By the configuration of HSCs in vitro culture medium and flow-cytometry sorting, a method was established to stably and highthroughput culture a single HSCs without the stroma cell support. Results The compound effect on the HSC was found inonly 10 to 14 days. The flow analysis of the differentiation, which substitutes the manual count, is a future saving of manpower. Conclusions This method is objective , reproducible and can be used in the high throughput screening of drugs.